However, as shown in Additional file 1, our findings that cystatin C and NGAL at day 3 performed better in predicting moderate to severe AKI (stage 2 or 3) compared with mild AKI (stage 1) is interesting, since worsened AKI severity is associated with an increased need for RRT and reduced survival [27]. This evidence concerns the gene LCN2 and acute kidney injury.